Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: An overview

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 6, 2012, Pages 658-678

  Ghazeeri, Ghina S ^a   Nassar, Anwar H ^a   Younes, Zeina ^a   Awwad, Johnny T ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Metformin; polycystic ovary syndrome; pregnancy outcome

Indexed keywords

CLOMIFENE CITRATE; METFORMIN; PLACEBO;

CLINICAL TRIAL; DRUG EFFECT; FIRST TRIMESTER PREGNANCY; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; HYPERTENSION; MATERNAL HYPERTENSION; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW;

ABORTION, SPONTANEOUS; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPERANDROGENISM; HYPERINSULINISM; HYPERTENSION, PREGNANCY-INDUCED; HYPOGLYCEMIC AGENTS; INFERTILITY, FEMALE; METFORMIN; OBESITY; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH;

EID: 84862097793     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2012.01385.x     Document Type: Review

References (55)

1. Boomsma CM, Eijkemans MJC, Hughes, EG, Visser GHA, Fauser BCJM, Macklon NS,. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006; 12: 673-83. (Pubitemid 44605508)
2. Nestler JE,. Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med. 2008; 358: 47-54.
3. Kaya C, Cengiz SD, Berker B, Demirtas S, Cesur M, Erdogen G, et al,. Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study. Fertil Steril. 2009; 92: 635-42.
4. Palomba S, Falbo A, Russo T, Tolino A, Orio F, Zullo F,. Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. Fertil Steril. 2010; 94: 1805-11.
5. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19: 41-7.
6. Carmina E, Azziz R,. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril. 2006; 86: S7-8.
7. Duleba AJ, Banaszewska B, Spaczynski RZ, Pawelczyk L,. Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial. Fertil Steril. 2006; 85: 996-1001.
8. Gambineri A, Pelusi C, Vicenanti V, Pagotto U, Pasquali R,. Obesity and the polycystic ovary syndrome. Int J Obes. 2002; 26: 883-96. (Pubitemid 34756169)
9. Franks S, Berga SL,. Does PCOS have developmental origins? Fertil Steril. 2012; 97: 2-6.
10. Haakova L, Cibula D, Rezabek K, Hill M, Fanta M, Zivny J,. Pregnancy outcome in women with PCOS and in controls matched by age and weight. Hum Reprod. 2003; 18: 1438-41. (Pubitemid 36840951)
11. Nestler JE, Clore JN, Blackard WG,. The central role of obesity (hyperinsulinemia) in the pathogenesis of polycystic ovary syndrome. Am J Obstet Gynecol. 1989; 161: 1095-7. (Pubitemid 20007659)
12. Kjerulff LE, Sanchez-Ramos L, Duffy D,. Pregnancy outcomes in women with polycystic ovary syndrome: a meta-analysis. Am J Obstet Gynecol. 2011; 204: 558.e1-6.
13. Altieri P, Gambineri A, Prontera O, Cionci G, Franchina M, Pasquali R,. Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol. 2010; 149: 31-6.
14. Homburg R,. Pregnancy complications in PCOS. Best Pract Res Clin Endocrinol Metabol. 2006; 20; 281-92. (Pubitemid 43842931)
15. Weerakiet S, Srisombut C, Rojanasakul A, Panburana P, Thakkinstian A, Herabutya Y,. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome. Gynecol Endocrinol. 2004; 19: 134-40. (Pubitemid 39486899)
16. Bjercke S, Dale PO, Tanbo T, Storeng R, Ertzeid G, Åbyholm T,. Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome. Gynecol Obstet Inves. 2002; 54: 94-8. (Pubitemid 36164639)
17. de Vries MJ, Dekker GA, Schoemaker J,. Higher risk of preeclampsia in the polycystic ovary syndrome: a case control study. Eur J Obstet Gynecol Reprod Biol. 1998; 91-5. (Pubitemid 28031991)
18. Diamant YZ, Rimon E, Evron S,. High incidence of preeclamptic toxemia in patients with polycystic ovarian disease. Eur J Obstet Gynecol Reprod Biol. 1982; 14: 199-204. (Pubitemid 13174422)
19. Diamanti-Kandarakis E, Alexandraki K, Protogerou A, Papamichael C, Aessopos A, et al,. Metformin administration improves endothelial function in women with polycystic ovary syndrome. Eur J Endocrinol. 2005; 152: 749-56. (Pubitemid 40744544)
20. Fougner KJ, Vanky E, Carlsen SM,. Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study. Scand J Clin Lab Invest. 2008; 68: 771-6.
21. Glueck CJ, Wang P, Fontaine RN, Sieve-Smith L, Tracy T, Moore SK,. Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. Metabolism. 1999; 48: 1589-95.
22. Glueck CJ, Phillips H, Cameron D, Sieve-Smith L, Wang P,. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril. 2001; 75: 46-52. (Pubitemid 32041226)
23. Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith L,. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril. 2002; 77: 520-5. (Pubitemid 34177206)
24. Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L,. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod. 2002; 17: 2858-64. (Pubitemid 35350902)
25. Glueck CJ, Bornovali S, Pranikoff J, Goldenberg N, Dharashivkar S, Wang P,. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome. Diabet Med. 2004; 21: 829-36. (Pubitemid 39036995)
26. Glueck CJ, Goldenberg N, Wang P, Loftspring M, Sherman A,. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod. 2004; 19: 510-21. (Pubitemid 38344509)
27. Glueck CJ, Pranikoff J, Aregawi D, Wang P,. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. Fertil Steril. 2008; 89: 625-34. (Pubitemid 351337664)
28. Hu S, Leonard A, Seifalian A, Hardiman P,. Vascular dysfunction during pregnancy in women with polycystic ovary syndrome. Hum Reprod. 2007; 22: 1532-9. (Pubitemid 47055139)
29. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Robers KA, Nestler JE,. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002; 87: 524-9. (Pubitemid 34158214)
30. Kashanian M, Fazy Z, Pirak A,. Evaluation of the relationship between gestational diabetes and a history of polycystic ovarian syndrome. Diabetes Res Clin Pract. 2008; 80: 289-92.
31. Kashyap S, Claman P,. Polycystic ovary disease and the risk of pregnancy-induced hypertension. J Reprod Med. 2000; 45: 991-4. (Pubitemid 32016799)
32. Kocak M, Caliskan E, Simsir C, Haberal A,. Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril. 2002; 77: 101- 6.
33. Lanzone A, Caruso A, Di Simone N, De Carolis S, Fulghesu AM, Mancuso S,. Polycystic ovary disease. A risk factor for gestational diabetes? J Reprod Med. 1995; 40: 312-6.
34. Lesser KB, Garcia FA,. Association between polycystic ovary syndrome and glucose intolerance during pregnancy. J Matern Fetal Med. 1997; 6: 303-7.
35. Lo JC, Feigenbaum SL, Escobar GJ, Yang J, Crites YM, Ferrara A,. Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome. Diabetes Care. 2006; 29: 1915-7. (Pubitemid 44156652)
36. Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A,. Obstetric outcome in women with PCOS. Hum Reprod. 2001; 16: 226-9.
37. Nawaz FH, Khalid R, Naru T, Rizvi J,. Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome? J Obstet Gynecol Res. 2008; 34: 832-7.
38. Paradisi G, Fulghesu AM, Ferrazzani S, Moretti S, Proto C, Soranna L, et al,. Endocrino-metabolic features in women with polycystic ovary syndrome during pregnancy. Hum Reprod. 1998; 13: 542-6. (Pubitemid 28171942)
39. Radon PA, McMahon MJ, Meyer WR,. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol. 1999; 94: 194-7. (Pubitemid 29352860)
40. Sir-Petermann T, Echiburú B, Maliqueo MM, Crisosto N, Sánchez F, Hitschfeld C, et al,. Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome. Hum Reprod 2007; 22: 1830-6. (Pubitemid 47062748)
41. Thatcher SS, Jackson EM,. Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin. Fertil Steril 2006; 85: 1002-9.
42. Turhan NO, Seçkin NC, Aybar F, Inegöl I,. Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients. Int J Gynecol Obstet. 2003; 81: 163-8. (Pubitemid 36434298)
43. Urman B, Sarac E, Dogan L, Gurgan T, Pregnancy in infertile PCOD patients. Complications and outcome. J Reprod Med. 1997; 42: 501-5. (Pubitemid 27360575)
44. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE,. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril. 2001; 75: 310-5. (Pubitemid 32112107)
45. Vanky E, Salvesen KA, Heimstad R, Fougner KJ, Romundstad P, Carlsen SM,. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod. 2004; 19: 1734-40. (Pubitemid 39144614)
46. Vanky E, Stridsklev S, Heimstad R, Romundstad P, Skogøy K, Kleggetveit O, et al,. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab. 2010; 95: E448-55.
47. Veltman-Verhulst SM, van Haeften TW, Eijkemans MJ, de Valk HW, Fauser BC, Goverde AJ,. Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome. Hum Reprod. 2010; 25: 3123-8.
48. Vollenhoven B, Clark S, Kovacs G, Burger H, Healy D,. Prevalence of gestational diabetes mellitus in polycystic ovarian syndrome (PCOS) patients pregnant after ovulation induction with gonadotrophins. Aust N Z J Obstet Gynecol. 2000; 40: 54-8. (Pubitemid 30153940)
49. Wang JX, Davies MJ, Norman RJ,. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod. 2001; 16: 2606-9. (Pubitemid 34007478)
50. Toulis KA, Goulis DG, Kolibianakis EM, Venetis CA, Tarlatzis BC, Papadimas I,. Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Fertil Steril. 2009; 92: 667-77.
51. Jakubowicz D, Sharma ST,. Insulin resistance and early pregnancy loss in polycystic ovary syndrome. In:, Diumanti-Kandarakis E, Nestler JE, Panidis D, Pasquali R, (Eds). Contemporary endocrinology: insulin resistance and polycystic ovarian syndrome: pathogenesis, evaluation, and treatment. Totowa, NJ: Humana Press Inc.; 2007. pp. 451-66.
52. Costello MF, Eden JA,. A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steril. 2003; 79: 1-13. (Pubitemid 36071228)
53. Bolton S, Cleary B, Walsh J, Dempsey E, Turner MJ,. Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity. Eur J Pediatr. 2009; 168: 203-6.
54. Palomba S, Falbo A, Orio F Jr, Zullo F,. Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 2009; 92: 1646-58.
55. Mathur R, Alexander CJ, Yano J, Trivax B, Azziz R,. Use of metformin in polycystic ovary syndrome. Am J Obstet Gynecol. 2008; 596-609.